Ascendis Pharma Reports Revenue Growth Despite Loss
Ascendis Pharma (ASND) has released an update. Ascendis Pharma has released its unaudited financial results for the period ending September 30, ...
Ascendis Pharma’s Q3 Growth and Strategic Moves
Ascendis Pharma (ASND) has released an update. Ascendis Pharma reported a revenue of €57.8 million in Q3 2024, driven by product launches and ...